A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...

LISBON — Patients with acute heart failure on the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin who received diuretic therapy experienced rapid decongestion with shorter hospital ...

Decompensated heart failure (DHF) means that symptoms from heart failure are severe enough to require immediate medical attention. Dyspnea or shortness of breath is the most common symptom of DHF.

Windtree Therapeutics, Inc. announced progress in its research on istaroxime and a selective SERCA2a activator, demonstrating a reduction in arrhythmias in an animal study, which will be presented at ...

Annual cardiologist visits for heart failure patients can reduce 1-year mortality by 6% to 9%, emphasizing the importance of specialist follow-up. The study identified disparities in cardiology care ...

Heart failure can strike suddenly and severely, leaving families desperate for solutions. Talking to HT Lifestyle, Dr. Anand R. Shenoy, Interventional Cardiologist at Manipal Hospital, Bengaluru, ...